File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Upregulation of the WNT co-receptor LRP6 in hepatocellular carcinoma

TitleUpregulation of the WNT co-receptor LRP6 in hepatocellular carcinoma
Authors
Issue Date2008
PublisherAmerican Association for Cancer Research
Citation
AACR 99th Annual Meeting, San Diego, CA, 12-16 April 2008. In Cancer Research, 2008, v. 68 n. 9S, Abstract no. 5255 How to Cite?
AbstractActivation of WNT/β-catenin signaling pathway is closely related to cancer formation including hepatocellular carcinoma (HCC), which is one of the commonest fatal cancers worldwide1. Low-density lipoprotein (LDL) receptor-related protein-5/6 (LRP5/6) are co-receptors for WNT ligands2 that have been studied in embryonic development but rarely in cancers3. We hypothesize that LRP6 is a putative oncogene in the WNT signaling pathway where its overexpression may play an important role in hepatocarcinogenesis. In this study, with immunofluorescence staining of LRP6-EGFP-transfected BEL7402, we observed that LRP6 displayed subcellular localization in the membrane as well as cytoplasm. Theexpressions of Wnts, their receptors frizzled (Fz) and LDL receptorlike proteins (LRP) and other Wnt sigaling pathway-related genes in human HCC samples were screened by quantitative RT-PCR using Taqman Low Density Array (LDA). We observed frequent upregulation (50%) of LRP6 expression at mRNA and protein levels in human HCCs, as compared with their corresponding non-tumorous livers. LRP6 protein expression level also positively correlated with that of beta-catenin in human HCCs. LRP6-EGFP-overexpressing and shRNA LRP6 knockdown stable clones were established for functional assays. The effects of LRP6 on Wnt/β-catenin signaling and cell proliferation were assessed in HCC cell lines. An increased protein expression level of β-catenin was found in LRP6-overexpressing stable clones. Interestingly, we observed that degradation of LRP6 might involve the proteosome/ubiquitination pathway through its D-box motif. Treatment with proteosome inhibitor MG132 in BEL7402 HCC cells and 293T cells resulted in an increased LRP6 protein expression. In addition, in vivo ubiquitination assay showed that LRP-Ub conjugation was enhanced by MG132 treatment. The results suggest that LRP6 is degraded via the proteasome/ubiquitination pathway through its D-box motif. To conclude, LRP6 is overexpressed in HCC and correlates positively with beta-catenin levels. Its degradation likely involves proteosome/ubiquitination pathway. Our data suggest that LRP6 may be a putative oncogenic gene and may have important role in hepatocarcinogenesis.
Persistent Identifierhttp://hdl.handle.net/10722/104464
ISSN
2015 Impact Factor: 8.556
2015 SCImago Journal Rankings: 5.372

 

DC FieldValueLanguage
dc.contributor.authorWong, YCen_HK
dc.contributor.authorYau, TOen_HK
dc.contributor.authorNg, IOLen_HK
dc.date.accessioned2010-09-25T21:54:09Z-
dc.date.available2010-09-25T21:54:09Z-
dc.date.issued2008en_HK
dc.identifier.citationAACR 99th Annual Meeting, San Diego, CA, 12-16 April 2008. In Cancer Research, 2008, v. 68 n. 9S, Abstract no. 5255-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/10722/104464-
dc.description.abstractActivation of WNT/β-catenin signaling pathway is closely related to cancer formation including hepatocellular carcinoma (HCC), which is one of the commonest fatal cancers worldwide1. Low-density lipoprotein (LDL) receptor-related protein-5/6 (LRP5/6) are co-receptors for WNT ligands2 that have been studied in embryonic development but rarely in cancers3. We hypothesize that LRP6 is a putative oncogene in the WNT signaling pathway where its overexpression may play an important role in hepatocarcinogenesis. In this study, with immunofluorescence staining of LRP6-EGFP-transfected BEL7402, we observed that LRP6 displayed subcellular localization in the membrane as well as cytoplasm. Theexpressions of Wnts, their receptors frizzled (Fz) and LDL receptorlike proteins (LRP) and other Wnt sigaling pathway-related genes in human HCC samples were screened by quantitative RT-PCR using Taqman Low Density Array (LDA). We observed frequent upregulation (50%) of LRP6 expression at mRNA and protein levels in human HCCs, as compared with their corresponding non-tumorous livers. LRP6 protein expression level also positively correlated with that of beta-catenin in human HCCs. LRP6-EGFP-overexpressing and shRNA LRP6 knockdown stable clones were established for functional assays. The effects of LRP6 on Wnt/β-catenin signaling and cell proliferation were assessed in HCC cell lines. An increased protein expression level of β-catenin was found in LRP6-overexpressing stable clones. Interestingly, we observed that degradation of LRP6 might involve the proteosome/ubiquitination pathway through its D-box motif. Treatment with proteosome inhibitor MG132 in BEL7402 HCC cells and 293T cells resulted in an increased LRP6 protein expression. In addition, in vivo ubiquitination assay showed that LRP-Ub conjugation was enhanced by MG132 treatment. The results suggest that LRP6 is degraded via the proteasome/ubiquitination pathway through its D-box motif. To conclude, LRP6 is overexpressed in HCC and correlates positively with beta-catenin levels. Its degradation likely involves proteosome/ubiquitination pathway. Our data suggest that LRP6 may be a putative oncogenic gene and may have important role in hepatocarcinogenesis.-
dc.languageengen_HK
dc.publisherAmerican Association for Cancer Research-
dc.relation.ispartofCancer Researchen_HK
dc.titleUpregulation of the WNT co-receptor LRP6 in hepatocellular carcinomaen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailYau, TO: yauto@hkucc.hku.hken_HK
dc.identifier.emailNg, IOL: iolng@hkucc.hku.hken_HK
dc.identifier.authorityNg, IOL=rp00335en_HK
dc.identifier.hkuros146625en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats